Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68788-8837

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68788-8837). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Venlafaxine HCl Extended-release Capsules 75mg (Venlafaxine 37.5mg 30s.jpg)

Venlafaxine HCl Extended-release Capsules 75mg (Venlafaxine 37.5mg 30s.jpg)
This text appears to be a description of Venlafaxine HCI Extended-Release capsules in 75mg dosage strength. It outlines caution against the transfer of the drug to anyone other than the prescribed patient due to federal regulations. The text also lists details such as the manufacturer (Granules India Limited), ingredients, expiration date, and a product identification number. Additionally, it specifies that the capsules are orange in color and imprinted with "G 75". Overall, the text provides essential information about the medication and its packaging.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.